Low frequency of epigenetic events in urothelial tumors in young patients

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 459-463

  Owen, Helen C ^a   Giedl, J ^c   Wild, Peter J ^d   Fine, Samson W ^e   Humphrey, Peter A ^f   Dehner, Louis P ^f   Amin, Mahul B ^g   Epstein, Johnathan I ^e   Blaszyk, H ^h   Hughes, David ^b   Hartmann, Arndt ^c   Stoehr, Robert ^c   Catto, James W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d ETH ZURICH   (Switzerland)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

^g EMORY UNIVERSITY HOSPITAL   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

age groups; carcinoma; methylation; urinary bladder; urothelium

Indexed keywords

APC PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN BCL 2; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; BLADDER UROTHELIAL CELL CARCINOMA; CANCER INCIDENCE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE FREQUENCY; GENE LOCUS; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR LOCALIZATION; UROGENITAL TRACT TUMOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA, TRANSITIONAL CELL; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 77955473071     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.131     Document Type: Article

References (24)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71
2. Globocan World Health Organization 2002 IARC Press Lyon
3. S.W. Fine, P.A. Humphrey, and L.P. Dehner Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification J Urol 174 2005 1976
4. O. Yossepowitch, and G. Dalbagni Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome J Urol 168 2002 61
5. J.N. Eble, G. Sauter, and J.I. Epstein Pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon 89 123
6. M. Burger, S. Denzinger, and W.F. Wieland Does the current World Health Oranization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset? BJU Int 102 2008 194
7. B. Liu, S.M. Farrington, and G.M. Petersen Genetic instability occurs in the majority of young patients with colorectal cancer Nat Med 1 1995 348
8. P.J. Wild, J. Giedl, and R. Stoehr Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger J Pathol 211 2007 18
9. J.W. Catto, A.R. Azzouzi, and I. Rehman Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma J Clin Oncol 23 2005 2903
10. D.R. Yates, I. Rehman, and M. Meuth Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls Oncogene 25 2006 1984
11. D.R. Yates, I. Rehman, and M.F. Abbod Promoter hypermethylation identifies progression risk in bladder cancer Clin Cancer Res 13 2007 2046
12. D. Dhawan, F.C. Hamdy, and I. Rehman Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma J Pathol 209 2006 336
13. C.M. Mueller, N. Caporaso, and M.H. Greene Familial and genetic risk of transitional cell carcinoma of the urinary tract Urol Oncol 26 2008 451
14. M. Roupret, O. Traxer, and M. Tligui Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection Eur Urol 51 2007 709
15. A. Hartmann, J.C. Cheville, and W. Dietmaier Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract Arch Pathol Lab Med 127 2003 E60
16. H. Blaszyk, L. Wang, and W. Dietmaier Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis Mod Pathol 15 2002 790
17. K. Matsumoto, A. Irie, and T. Satoh Occupational bladder cancer: from cohort study to biologic molecular marker Med Sci Monit 11 2005 RA311
18. L. Dyrskjot, M. Kruhoffer, and T. Thykjaer Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification Cancer Res 64 2004 4040
19. M.G. Friedrich, D.J. Weisenberger, and J.C. Cheng Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients Clin Cancer Res 10 2004 7457
20. A. Almasan, and A. Ashkenazi Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy Cytokine Growth Factor Rev 14 2003 337
21. J.K. Earel Jr, R.L. VanOosten, and T.S. Griffith Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells Cancer Res 66 2006 499
22. M. Sanchez-Carbayo, N.D. Socci, and J. Lozano Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays J Clin Oncol 24 2006 778
23. M. Oya, B. Schmidt, and B.J. Schmitz-Drager Expression of G1>S transition regulatory molecules in human urothelial cancer Jpn J Cancer Res 89 1998 719
24. B. Kwabi-Addo, W. Chung, and L. Shen Age-related DNA methylation changes in normal human prostate tissues Clin Cancer Res 13 2007 3796